| NCT04488601 |
AgelessRx|University of California, Los Angeles |
Aging
|
2020-01-01 |
PHASE2 |
| NCT05190627 |
Institut d´Investigació Biomèdica de Bellvitge |
Lymphangioleiomyomatosis
|
2021-11-01 |
PHASE2 |
| NCT06743503 |
Nanjing IASO Biotechnology Co., Ltd.|The First Affiliated Hospital with Nanjing Medical University |
Large B-cell Lymphoma
|
2025-04-11 |
PHASE1 |
| NCT01255956 |
Medical University of Warsaw|KCRI |
In-Stent Restenosis
|
2010-12 |
PHASE3 |
| NCT01684449 |
Grupo Espanol de Investigacion en Sarcomas |
Advanced Soft Tissue Sarcoma
|
2010-01 |
PHASE1|PHASE2 |
| NCT00457808 |
Children´s Hospital Medical Center, Cincinnati|The LAM Foundation|Tuberous Sclerosis Alliance |
Tuberous Sclerosis|Lymphangioleiomyomatosis
|
2002-12 |
PHASE2 |
| NCT00402415 |
Yale University|Pfizer |
Tumors
|
2006-02 |
PHASE1 |
| NCT00304954 |
National Eye Institute (NEI) |
Age-Related Macular Degeneration|Choroidal Neovascularization
|
2006-02 |
PHASE2 |
| NCT01678937 |
Northwestern University|Northwestern Memorial Hospital |
Liver Transplant Rejection|Immunosuppression
|
2007-09 |
|
| NCT06029569 |
Shanghai Bomaian Medical Technology Co., Ltd |
Peripheral Arterial Disease
|
2023-09-15 |
NA |
| NCT05342519 |
Medical University of South Carolina|American Skin Association |
Vitiligo
|
2022-07-28 |
PHASE2 |
| NCT01014234 |
Fondazione IRCCS Policlinico San Matteo di Pavia |
Kidney Transplantation
|
2008-07 |
PHASE2 |
| NCT06653842 |
Palvella Therapeutics, Inc. |
Cutaneous Venous Malformations
|
2024-12-20 |
PHASE2 |
| NCT00533442 |
University of Miami|Astellas Pharma Inc |
Type 1 Diabetes
|
2000-09 |
PHASE2 |
| NCT00707135 |
University of Chicago|National Institutes of Health (NIH) |
Advanced Cancer
|
2005-06 |
PHASE1 |
| NCT00276744 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Pancreatic Cancer
|
2005-10 |
PHASE2 |
| NCT06658093 |
The University of Texas Health Science Center at San Antonio|National Institute on Aging (NIA) |
Aging
|
2025-08-13 |
EARLY_PHASE1 |
| NCT00401115 |
Santen Inc.|MacuSight, Inc. |
Diabetic Macular Edema|Diabetic Retinopathy
|
2006-09 |
PHASE1 |
| NCT07570433 |
Oriol Manuel|Centre Hospitalier Universitaire Bordeaux|Centre Hospitalier Universitaire de Toulouse, FRANCE|Hospital Vall d´Hebron |
CMV Infection
|
2026-04 |
PHASE4 |
| NCT02596828 |
University of Regensburg |
Pineoblastoma
|
2016-04 |
PHASE2 |
| NCT02675153 |
The Second Hospital of Nanjing Medical University |
Crohn´s Diseases
|
2015-04-01 |
NA |
| NCT00830466 |
University of California, Irvine|Beckman Laser Institute University of California Irvine|Pfizer |
Port Wine Stain
|
2008-12 |
PHASE1 |
| NCT04482712 |
The University of Texas Health Science Center at San Antonio|The Claude D. Pepper Older Americans Independence Centers |
Acute Lung Injury+Acute Respiratory Distress Syndrome (ARDS)|Respiratory Failure|Sars-CoV2
|
2021-04 |
PHASE1|PHASE2 |
| NCT07436611 |
AFT Pharmaceuticals, Ltd. |
Port Wine Stains
|
2026-04 |
PHASE2 |
| NCT07354620 |
The Christ Hospital |
Aging
|
2025-02-15 |
EARLY_PHASE1 |
| NCT02080624 |
Clinica Universidad de Navarra, Universidad de Navarra |
Sturge- Weber Syndrome
|
2011-01 |
PHASE2 |
| NCT01054313 |
M.D. Anderson Cancer Center |
Advanced Cancer
|
2010-01 |
PHASE1 |
| NCT04608448 |
The University of Texas Health Science Center at San Antonio|National Institute on Aging (NIA) |
Aging|Epigenetics|Inflammatory Mediators
|
2021-04-28 |
EARLY_PHASE1 |
| NCT02688842 |
Shanghai MicroPort Medical (Group) Co., Ltd. |
Coronary Heart Disease
|
2014-05 |
NA |
| NCT00874562 |
Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Boston Children´s Hospital|National Cancer Institute (NCI) |
Acute Lymphoblastic Leukemia
|
2007-07 |
PHASE1 |
| NCT07092618 |
AgelessRx |
Longevity|GLP-1|Geroscience|Aging
|
2024-12-17 |
PHASE2|PHASE3 |
| NCT03359538 |
Azienda Ospedaliero-Universitaria di Modena|University of Modena and Reggio Emilia|Azienda Ospedaliero Universitaria Maggiore della Carita|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|University of Turin, Italy|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|Azienda Ospedaliera Niguarda Cà Granda|Fondazione Salvatore Maugeri|University of Padova |
Amyotrophic Lateral Sclerosis
|
2017-09-19 |
PHASE2 |
| NCT00241189 |
University of California, Los Angeles |
Systemic Sclerosis
|
2002-08 |
PHASE1|PHASE2 |
| NCT06550271 |
AgelessRx |
Aging
|
2023-04-25 |
|
| NCT03243019 |
University Hospital, Lille|Ministry of Health, France |
Lymphatic Malformation|Pediatric
|
2018-06-25 |
PHASE2 |
| NCT00708591 |
University of Chicago |
Advanced Cancer
|
2004-10 |
PHASE1 |
| NCT01467986 |
University of Regensburg |
Neuroblastoma Recurrent
|
2013-08 |
PHASE2 |
| NCT06308445 |
University Hospital, Toulouse |
Familial Adenomatous Polyposis
|
2026-09-01 |
PHASE2 |
| NCT05233722 |
University of Copenhagen|Danish Diabetes Academy |
Insulin Sensitivity
|
2022-02-10 |
NA |
| NCT05532072 |
First Affiliated Hospital Xi´an Jiaotong University|Beijing Tongren Hospital|Cheloo Hospital (Qingdao), Shandong University|Jiangsu Province Hospital with Integration of Chinese and Western Medicine|Nanjing First Hospital, Nanjing Medical University|Zhejiang Provincial People´s Hospital|Southern Medical University, China|People´s Hospital of Xinjiang Uygur Autonomous Region|The Second Affiliated Hospital of Air Force Military Medical University |
Graves Ophthalmopathy
|
2022-09 |
EARLY_PHASE1 |
| NCT00583063 |
University of Chicago|Pfizer |
Solid Tumors
|
2007-10 |
EARLY_PHASE1 |
| NCT00223678 |
Vanderbilt University Medical Center |
Kidney Transplant
|
2000-06 |
PHASE4 |
| NCT07475546 |
AgelessRx |
Healthspan Improvement|Aging|Longevity
|
2025-07-23 |
PHASE3 |
| NCT05180708 |
Palvella Therapeutics, Inc. |
Pachyonychia Congenita
|
2021-11-29 |
PHASE3 |
| NCT02688829 |
Shanghai MicroPort Medical (Group) Co., Ltd. |
Coronary Heart Disease
|
2009-12 |
NA |
| NCT05605665 |
Peking University People´s Hospital |
Sj?gren´s Syndrome
|
2022-12-05 |
PHASE1|PHASE2 |
| NCT05144698 |
Rapa Therapeutics LLC |
Solid Tumor|Small Cell and Non-small Cell Lung Cancer|Head and Neck Cancer|Squamous Cell Carcinoma of Oral Cavity|Squamous Cell Carcinoma of Larynx|Squamous Cell Carcinoma of Nasopharynx|Squamous Cell Carcinoma of Other Specified Sites of Skin|Malignant Melanoma|Esophageal Squamous Cell Carcinoma
|
2021-08-01 |
PHASE1|PHASE2 |
| NCT02646319 |
Mayo Clinic|National Cancer Institute (NCI) |
Advanced Malignant Neoplasm|Cervical Squamous Cell Carcinoma|Endometrial Carcinoma|Malignant Uterine Neoplasm|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Malignant Neoplasm|Recurrent Ovarian Carcinoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Solid Neoplasm|Stage III Bladder Cancer|Stage III Prostate Cancer|Stage III Renal Cell Cancer|Stage IIIA Breast Cancer|Stage IIIA Cervical Cancer|Stage IIIA Ovarian Cancer|Stage IIIB Breast Cancer|Stage IIIB Cervical Cancer|Stage IIIB Ovarian Cancer|Stage IIIC Breast Cancer|Stage IIIC Ovarian Cancer|Stage IV Breast Cancer|Stage IV Ovarian Cancer|Stage IV Prostate Cancer|Stage IV Renal Cell Cancer|Stage IVA Bladder Cancer|Stage IVA Cervical Cancer|Stage IVB Bladder Cancer|Stage IVB Cervical Cancer
|
2016-01 |
EARLY_PHASE1 |
| NCT02481453 |
Institut National de la Santé Et de la Recherche Médicale, France |
Inclusion Body Myositis (IBM)
|
2015-07-15 |
PHASE2|PHASE3 |
| NCT01672151 |
First Affiliated Hospital of Suzhou Medical College |
Immune Thrombocytopenic Purpura
|
2011-11 |
|
| NCT02048384 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Stand Up To Cancer |
Metastatic Pancreatic Adenocarcinoma
|
2014-06-10 |
PHASE1 |
| NCT00779194 |
State University of New York - Upstate Medical University|Pfizer |
Systemic Lupus Erythematosus (SLE)
|
2008-10 |
PHASE2 |
| NCT00780104 |
Abramson Cancer Center at Penn Medicine |
Myeloid Leukemias|AML|Leukemia|CML
|
2007-07 |
PHASE1 |
| NCT00908466 |
Johns Hopkins University|MacuSight, Inc. |
Uveitis|Intermediate Uveitis|Posterior Uveitis|Panuveitis
|
2009-07 |
PHASE1 |
| NCT01526356 |
The University of Texas Health Science Center, Houston |
Angiofibromas|Tuberous Sclerosis
|
2012-05 |
PHASE2 |
| NCT00803010 |
H. Lee Moffitt Cancer Center and Research Institute |
Acute Graft Versus Host Disease
|
2008-09 |
PHASE2 |
| NCT03383380 |
Children´s Hospital of Fudan University |
Activated PI3K-delta Syndrome|Immunodeficiency Primary
|
2017-12-01 |
PHASE1|PHASE2 |
| NCT06257420 |
Simmaron Research Inc.|Center For Complex Diseases-Seattle, WA|Sierra Internal Medicine, Incline Village, NV|Center for Complex Diseases- Palo Alto, CA|Simmaron Research Inc. R&D Lab, University of Wisconsin, Milwaukee (UWM)|Bateman Horne Center, Salt Lake City, UT|Mayo Clinic |
Myalgic Encephalomyelitis|Long-COVID
|
2023-12-11 |
|
| NCT00891696 |
The University of Texas Medical Branch, Galveston|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
Sarcopenia
|
2009-04 |
PHASE1 |
| NCT04742777 |
The University of Texas Health Science Center at San Antonio|The Claude D. Pepper Older Americans Independence Centers|National Institute on Aging (NIA) |
Aging
|
2022-02-01 |
PHASE2 |
| NCT02803892 |
Piemonti Lorenzo|Italian Diabetes Foundation |
Diabetes Mellitus, Type 1
|
2016-05 |
PHASE2 |
| NCT00311623 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Prostate Cancer
|
2006-08 |
PHASE1|PHASE2 |
| NCT01183247 |
University Hospital, Basel, Switzerland|Novartis |
Comparative Study|Immunosuppressive Agents
|
2008-07 |
PHASE4 |
| NCT00123331 |
Heidelberg University|Wyeth is now a wholly owned subsidiary of Pfizer |
Heart Transplantation|Renal Failure
|
2003-10 |
PHASE4 |
| NCT00235560 |
University Hospital, Toulouse|French Innovative Leukemia Organisation |
Acute Myeloid Leukemia
|
2005-06 |
PHASE2 |
| NCT03767660 |
Peking Union Medical College Hospital|Air Force General Hospital of the PLA|Chinese Academy of Medical Sciences |
Blue Rubber Bleb Nevus Syndrome|Venous Malformation
|
2018-07-31 |
PHASE4 |
| NCT07058974 |
Icahn School of Medicine at Mount Sinai |
Smokers|Former Smokers
|
2025-08-25 |
PHASE1 |
| NCT01282697 |
University Hospital, Strasbourg, France|Gustave Roussy, Cancer Campus, Grand Paris |
Refractory Solid Tumors in Children
|
2011-04-22 |
PHASE1 |
| NCT03500367 |
Peking Union Medical College Hospital |
Uterine Fibroids
|
2018-01-01 |
PHASE4 |
| NCT03781050 |
Peking Union Medical College Hospital|Air Force General Hospital of the PLA|Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Peutz-Jeghers Syndrome
|
2018-09-16 |
PHASE4 |
| NCT06683118 |
MicroPort NeuroTech Co., Ltd. |
Cerebral Atherosclerotic Stenosis
|
2024-05-27 |
NA |
| NCT00306397 |
University Hospital, Basel, Switzerland |
Kidney Transplantation
|
2005-01 |
PHASE4 |
| NCT03298958 |
The University of Texas Health Science Center at San Antonio |
Bladder Cancer
|
2018-11-01 |
PHASE3 |
| NCT01396200 |
Abramson Cancer Center at Penn Medicine |
Myeloma
|
2011-06 |
EARLY_PHASE1 |
| NCT00467194 |
National Cancer Centre, Singapore |
Liver Cancer
|
2006-12 |
PHASE1 |
| NCT01649960 |
Mayo Clinic |
Aging|CAD
|
2012-08 |
PHASE1 |
| NCT06239480 |
Palvella Therapeutics, Inc.|FDA Office of Orphan Products Development |
Microcystic Lymphatic Malformation
|
2024-07-31 |
PHASE3 |
| NCT03732248 |
Medical University of South Carolina |
Alcohol Use Disorder|Alcohol Dependence
|
2018-07-12 |
PHASE1 |
| NCT00133887 |
Hospices Civils de Lyon |
Skin Cancer|Kidney Transplantation
|
2004-04 |
PHASE3 |
| NCT03826628 |
Dermatology Specialties Limited Partnership |
Facial Angiofibroma|Tuberous Sclerosis
|
2019-07-28 |
PHASE2|PHASE3 |
| NCT03161340 |
Mehdi Yousefi |
Recurrent Implantation Failure
|
2017-07-11 |
PHASE2 |
| NCT00598533 |
Deutsches Herzzentrum Muenchen |
Coronary Heart Disease
|
2008-02 |
PHASE4 |
| NCT00411788 |
Yale University|Genentech, Inc. |
Breast Cancer
|
2006-12 |
PHASE2 |
| NCT03140449 |
National Taiwan University Hospital |
Facial Angiofibroma
|
2013-09-05 |
PHASE3 |
| NCT06563817 |
Beijing Tiantan Hospital |
Communicating Hydrocephalus|Cerebral Intraventricular Hemorrhage|Secondary Normal Pressure Hydrocephalus|Post Hemorrhagic Hydrocephalus
|
2024-08 |
PHASE2 |
| NCT05836025 |
Columbia University |
Perimenopausal
|
2023-06-01 |
PHASE2 |
| NCT03112603 |
Incyte Corporation |
Graft-versus-host Disease (GVHD)
|
2017-06-29 |
PHASE3 |
| NCT00290069 |
Sociedad Andaluza de Trasplantes de Organos y Tejidos |
Kidney Diseases|Graft Rejection
|
|
PHASE4 |
| NCT01903473 |
University of Liege |
Chronic Graft-Versus-Host Disease|Acute Graft-Versus-Host Disease|Steroid Refractory Graft-Versus-Host Disease
|
2013-07 |
PHASE2 |
| NCT01449955 |
University of Texas Southwestern Medical Center|North Texas Veterans Healthcare System |
Posttraumatic Stress Disorder
|
2008-08 |
NA |
| NCT00901849 |
Roger Packer|Children´s National Research Institute |
Low-grade Gliomas
|
2007-05 |
PHASE1 |
| NCT00800722 |
University of California, Irvine|Pfizer|Beckman Laser Institute University of California Irvine |
Port Wine Stain
|
2008-11 |
PHASE1 |
| NCT02844270 |
Shanghai Bio-heart Biological Technology Co., Ltd. |
Heart Diseases
|
2016-08-09 |
NA |
| NCT01060605 |
IRCCS San Raffaele|Ministry of Education, Universities and Research, Italy|Juvenile Diabetes Research Foundation|Telethon-JDRF Center for Beta cell replacement: clinical core. |
Diabetes Mellitus, Type 1
|
2001-10 |
PHASE3 |
| NCT00286156 |
The Cleveland Clinic|Wyeth is now a wholly owned subsidiary of Pfizer |
Polycystic Kidney Diseases
|
2006-10 |
PHASE1|PHASE2 |
| NCT01853423 |
Le Bonheur Children´s Hospital|Pfizer|University of Tennessee |
Facial Angiofibroma
|
2013-10 |
PHASE1 |
| NCT00922129 |
St. Joseph´s Healthcare Hamilton |
Prostate Cancer
|
2009-09 |
PHASE2|PHASE3 |
| NCT00896012 |
University at Buffalo|Novartis|University of Washington |
Kidney Transplantation
|
2008-01 |
PHASE4 |
| NCT00195481 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Kidney Failure|Graft vs Host Disease
|
2004-04 |
PHASE4 |
| NCT07033858 |
Shahid Beheshti University of Medical Sciences |
Kidney Transplant; Complications
|
2025-03-01 |
NA |
| NCT04200911 |
The University of Texas Health Science Center at San Antonio|National Center for Advancing Translational Sciences (NCATS) |
Cognitive Impairment, Mild|Alzheimer Disease
|
2020-06-01 |
EARLY_PHASE1 |
| NCT00252655 |
Wayne State University |
Kidney Transplantation
|
2004-01 |
PHASE4 |
| NCT03214354 |
University of Calgary |
Sickle Cell Disease|Stem Cell Transplant Complications|Red Blood Cell Disorder|Pure Red Cell Aplasia
|
2017-07-05 |
PHASE2 |
| NCT00092222 |
National Cancer Institute (NCI) |
Lymphoproliferative Disorder|HHV-8|Malignancy|HIV
|
2004-10-28 |
PHASE2 |
| NCT01061853 |
University Hospital, Tours|Institut National de la Santé Et de la Recherche Médicale, France |
Oral Lichen Planus
|
2008-02 |
PHASE3 |
| NCT06160739 |
Sohag University |
Microcystic Lymphatic Malformation|Combined Vascular Malformation|Vascular Malformations
|
2023-11-20 |
|
| NCT04959175 |
National Cancer Institute (NCI) |
Hematologic Neoplasms
|
2021-09-23 |
PHASE1|PHASE2 |
| NCT03121001 |
University of Illinois at Chicago |
Sickle Cell Disease
|
2017-03-20 |
PHASE2 |
| NCT05625919 |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
|
2022-11-08 |
PHASE1|PHASE2 |
| NCT04736953 |
State University of New York - Upstate Medical University |
Lupus Erythematosus, Systemic
|
2025-01-01 |
PHASE2 |
| NCT01462006 |
University of Virginia|National Heart, Lung, and Blood Institute (NHLBI) |
Idiopathic Pulmonary Fibrosis|Diffuse Parenchymal Lung Disease|Interstitial Lung Disease
|
2011-10 |
NA |
| NCT01106833 |
Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Blood and Marrow Transplant Clinical Trials Network|National Marrow Donor Program |
Chronic GVHD
|
2010-04 |
PHASE2|PHASE3 |
| NCT06959771 |
National Institute of Allergy and Infectious Diseases (NIAID) |
CD40L-HyperIgM Syndrome
|
2025-07-16 |
PHASE1|PHASE2 |
| NCT06287944 |
City of Hope Medical Center|National Cancer Institute (NCI) |
Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Myelodysplastic Syndrome
|
2025-07-01 |
PHASE1 |
| NCT04324411 |
Peking Union Medical College Hospital |
Autoimmune Anemia
|
2020-04-01 |
PHASE2|PHASE3 |
| NCT00195429 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Kidney Failure|Graft vs Host Disease
|
2005-08 |
PHASE4 |
| NCT06876142 |
National Cancer Institute (NCI) |
Multiple Myeloma|Relapsed and+or Refractory Multiple Myeloma (RRMM)
|
2026-05-13 |
PHASE1|PHASE2 |
| NCT02960997 |
Stanford University |
Epidermolysis Bullosa Simplex|Epidermolysis Bullosa Simplex Kobner|Weber-Cockayne Syndrome
|
2016-05 |
PHASE2 |
| NCT02443818 |
Centre Hospitalier Universitaire Dijon |
Segmental Overgrowth Disorders Due to PIK3CA
|
2015-05 |
PHASE2 |
| NCT07162038 |
National Cancer Institute (NCI) |
Hematologic Malignancies|Hematologic Neoplasms
|
2025-11-14 |
PHASE1 |
| NCT03016715 |
Premier Specialists, Australia |
Epidermolysis Bullosa Simplex|Epidermolysis Bullosa Simplex Kobner|Weber-Cockayne Syndrome
|
2016-05 |
PHASE2 |
| NCT04408625 |
Prevail Therapeutics|Eli Lilly and Company |
Frontotemporal Dementia
|
2020-11-09 |
PHASE1|PHASE2 |
| NCT01318915 |
National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) |
Renal Transplant Recipients
|
2011-07-25 |
EARLY_PHASE1 |
| NCT04598815 |
University of Pisa |
Graves Ophthalmopathy
|
2023-06-01 |
PHASE2 |
| NCT00321906 |
University of Chicago|Astellas Pharma Inc|Loyola University|University of Florida|University of Pennsylvania|Baylor College of Medicine|Ochsner Health System|Columbia University|University of Wisconsin, Madison |
Delayed Graft Function|Acute Graft Rejection
|
2002-04 |
PHASE4 |
| NCT02683291 |
Associa??o Médico Espírita de Botucatu |
Disorder Related to Renal Transplantation|Cytomegalovirus Infections
|
2014-01 |
PHASE4 |
| NCT01791088 |
University of Chicago|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific
|
2012-06-13 |
PHASE1 |
| NCT04362293 |
St. Jude Children´s Research Hospital |
Sickle Cell Disease
|
2020-04-30 |
PHASE2 |
| NCT03605927 |
H. Lee Moffitt Cancer Center and Research Institute|Bristol-Myers Squibb |
Graft-versus-host-disease|GVHD|GVHD, Acute
|
2019-02-15 |
PHASE1 |
| NCT00076570 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Kidney Transplantation
|
2004-01 |
PHASE2 |
| NCT02793544 |
Center for International Blood and Marrow Transplant Research|National Marrow Donor Program |
Myelodysplastic Syndrome (MDS)|Chronic Lymphocytic Leukemia (CLL)|Chemotherapy-sensitive Lymphoma|Acute Lymphoblastic Leukemia (ALL)+T Lymphoblastic Lymphoma|Acute Myelogenous Leukemia (AML)|Acute Biphenotypic Leukemia (ABL)|Acute Undifferentiated Leukemia (AUL)
|
2016-12 |
PHASE2 |
| NCT01120028 |
University of Oxford|National Health Service, United Kingdom|Pfizer|Novartis |
Kidney Transplantation
|
2010-09 |
PHASE2|PHASE3 |
| NCT03780192 |
Scitech Produtos Medicos SA |
Bifurcation Lesion|Coronary Artery Disease
|
2019-02-28 |
|
| NCT00491517 |
Mario Negri Institute for Pharmacological Research |
Polycystic Kidney
|
2007-03 |
PHASE2 |
| NCT06075368 |
Genoss Co., Ltd. |
Acute Coronary Syndrome|Percutaneous Coronary Intervention
|
2020-03-16 |
|
| NCT02126527 |
Mayo Clinic|National Cancer Institute (NCI) |
Recurrent Non-small Cell Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific
|
2013-08 |
PHASE1 |
| NCT02117596 |
Pediatric Nephrology of Alabama|Pfizer|The Emmes Company, LLC |
Renal Transplant
|
2007-11 |
NA |
| NCT02722668 |
Masonic Cancer Center, University of Minnesota |
Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia+Lymphoma|Burkitt´s Lymphoma|Natural Killer Cell Malignancies|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome|Large-cell Lymphoma|Hodgkin Lymphoma|Multiple Myeloma|Relapsed Chronic Lymphocytic Leukemia|Relapsed Small Lymphocytic Lymphoma|Marginal Zone B-cell Lymphoma|Follicular Lymphoma|Lymphoplasmacytic Lymphoma|Mantle-cell Lymphoma|Prolymphocytic Leukemia|Bone Marrow Failure Syndromes|Myeloproliferative Neoplasms+Myelofibrosis|Biphenotypic+Undifferentiated+Prolymphocytic Leukemias|MRD Positive Leukemia|Leukemia or MDS in Aplasia|Relapsed T-Cell Lymphoma|Relapsed Multiple Myeloma|Plasma Cell Leukemia
|
2017-05-15 |
PHASE2 |
| NCT05327023 |
National Cancer Institute (NCI) |
Hematologic Neoplasms
|
2022-05-23 |
PHASE1|PHASE2 |
| NCT00426517 |
National Institute of Allergy and Infectious Diseases (NIAID) |
Inherited Immune Deficiencies
|
2007-01-19 |
EARLY_PHASE1 |
| NCT01754389 |
Dana-Farber Cancer Institute |
Graft Versus Host Disease
|
2013-01 |
PHASE2 |
| NCT02062944 |
Northwestern University |
Acute Rejection of Liver Transplant|Effects of Immunosuppressant Therapy
|
2013-03 |
NA |
| NCT00317798 |
University of Rochester |
Drug+Agent Toxicity by Tissue+Organ|Multiple Myeloma and Plasma Cell Neoplasm
|
2006-04 |
PHASE1 |
| NCT00602693 |
Masonic Cancer Center, University of Minnesota |
Leukemia|Lymphoma|Multiple Myeloma|Plasma Cell Neoplasm|Myelodysplastic Syndromes
|
2007-07-23 |
PHASE1 |
| NCT04707209 |
The Hospital for Sick Children |
Retinal Astrocytic Hamartoma
|
2020-11-04 |
NA |
| NCT02208791 |
University of Sao Paulo General Hospital |
Kidney Transplantation
|
2014-07 |
PHASE4 |
| NCT04511247 |
Concept Medical Inc. |
Peripheral Artery Disease|Atherosclerosis|Arterial Disease of Legs
|
2020-08-15 |
NA |
| NCT00317785 |
Fred Hutchinson Cancer Center|National Cancer Institute (NCI) |
Leukemia|Lymphoma|Myelodysplastic Syndromes
|
2005-05 |
PHASE2 |
| NCT00792948 |
National Cancer Institute (NCI) |
Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Adult L1 Acute Lymphoblastic Leukemia|Adult L2 Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia
|
2009-09-01 |
PHASE2 |
| NCT07165886 |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Gastroenteropancreatic Neuroendocrine Tumors
|
2025-08-29 |
PHASE2|PHASE3 |
| NCT02995096 |
Rigshospitalet, Denmark |
Liver Transplantation
|
2016-01 |
|
| NCT03253913 |
University of Cincinnati|National Heart, Lung, and Blood Institute (NHLBI) |
Lymphangioleiomyomatosis
|
2018-03-31 |
PHASE2 |
| NCT04582136 |
Chinese SLE Treatment And Research Group|Beijing Municipal Science & Technology Commission|North China Pharmaceutical Group Corporation |
Systemic Lupus Erythematosus
|
2021-03-04 |
PHASE3 |
| NCT05386914 |
University of Missouri-Columbia |
Genetic Predisposition to Disease|Healthy Volunteers
|
2023-03-02 |
PHASE1 |
| NCT00388362 |
Stanford University |
Graft vs Host Disease
|
2005-11 |
PHASE2 |
| NCT05719883 |
Beijing Tiantan Hospital|Alain Medical (Beijing) Co., Ltd. |
Intracranial Arteriosclerosis|Stroke (CVA) or TIA
|
2023-02-20 |
NA |
| NCT01802268 |
Helio Tedesco Silva Junior|Pfizer |
Kidney Transplant
|
2008-02 |
PHASE4 |
| NCT03292861 |
Cedars-Sinai Medical Center|Genzyme, a Sanofi Company |
Heart Transplantation
|
2018-09-13 |
PHASE2 |
| NCT00999258 |
Temple University|Wyeth is now a wholly owned subsidiary of Pfizer |
Glomerular Filtration Rate|Chronic Allograft Nephropathy
|
2009-09 |
PHASE4 |
| NCT00305682 |
Masonic Cancer Center, University of Minnesota |
Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes
|
2005-06 |
PHASE2 |
| NCT00544115 |
City of Hope Medical Center|National Cancer Institute (NCI) |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Precancerous+Nonmalignant Condition
|
2001-10-16 |
PHASE2 |
| NCT04612179 |
IHF GmbH - Institut für Herzinfarktforschung |
Coronary Disease
|
2021-06-23 |
|
| NCT01217125 |
Fundacio Puigvert|Ministry of Health, Spain |
Angiomyolipoma
|
2008-10 |
PHASE4 |
| NCT03660930 |
University of Washington|Aadi Bioscience, Inc. |
Advanced Soft Tissue Sarcoma|Locally Advanced Soft Tissue Sarcoma|Metastatic Soft Tissue Sarcoma
|
2019-04-01 |
PHASE1|PHASE2 |
| NCT04921722 |
Children´s Hospital of Fudan University |
Kaposiform Hemangioendothelioma|Tufted Angioma|Superficial Vascular Anomalies|Superficial Lymphatic Malformations
|
2021-10-22 |
PHASE4 |
| NCT01087554 |
M.D. Anderson Cancer Center |
Advanced Cancer
|
2010-03 |
PHASE1 |
| NCT00166829 |
National Taiwan University Hospital |
Kidney Transplantation
|
2004-05 |
PHASE4 |
| NCT00821080 |
Massachusetts General Hospital|Brigham and Women´s Hospital|Dana-Farber Cancer Institute|AstraZeneca |
Glioblastoma
|
2008-10 |
PHASE1 |
| NCT00934791 |
Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer |
Polycystic Liver Disease
|
2009-02 |
NA |
| NCT00130546 |
University Hospital Freiburg|Cordis Medizinische Apparate GmbH |
Coronary Artery Disease
|
2004-11 |
PHASE3 |
| NCT02517918 |
Institut Bergonié|Reliable Cancer Therapies|Pfizer |
Solid Tumor|Osteosarcoma
|
2015-02 |
PHASE1 |
| NCT06271590 |
Concept Medical Inc.|Cardiovascular Research Foundation, New York |
Coronary Artery Disease|Native Coronary Artery Stenosis|Cardiovascular Diseases
|
2025-05-20 |
NA |
| NCT01927120 |
H. Lee Moffitt Cancer Center and Research Institute |
Graft-Versus-Host-Disease
|
2014-03-25 |
PHASE2 |
| NCT00118742 |
Hoffmann-La Roche |
Liver Transplantation
|
2005-08 |
PHASE4 |
| NCT00346151 |
National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) |
Renal Transplant
|
2006-12 |
PHASE2 |
| NCT00079183 |
Fred Hutchinson Cancer Center|National Cancer Institute (NCI) |
Graft Versus Host Disease
|
2002-04 |
PHASE2 |
| NCT02574728 |
Emory University|Cannonball Kids´ Cancer Foundation|Hyundai Hope On Wheels |
Cancer
|
2015-06 |
PHASE2 |
| NCT05556681 |
C. R. Bard |
Peripheral Arterial Disease|Peripheral Artery Disease|Stenosis Artery
|
2022-08-02 |
NA |
| NCT07241936 |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Advanced Solid Tumors
|
2025-11-13 |
PHASE1|PHASE2 |
| NCT04698512 |
Singapore General Hospital |
Dialysis Access Malfunction|End Stage Renal Failure on Dialysis|End Stage Renal Disease|Fistulas Arteriovenous|Stenosis
|
2019-05-21 |
|
| NCT00023244 |
National Institute of Allergy and Infectious Diseases (NIAID)|Cooperative Clinical Trials in Pediatric Transplantation |
End-Stage Renal Disease
|
2001-01 |
PHASE2 |
| NCT00940381 |
M.D. Anderson Cancer Center |
Advanced Cancer
|
2009-07 |
PHASE1 |
| NCT01958190 |
Foundation for Liver Research |
Liver Disease
|
2011-02-07 |
PHASE4 |
| NCT02282904 |
National Institute of Allergy and Infectious Diseases (NIAID) |
Chronic Granulomatous Disease
|
2014-10-23 |
PHASE1|PHASE2 |
| NCT00374647 |
University of Cincinnati |
Primary Renal Allograft
|
2005-03 |
PHASE4 |
| NCT05458492 |
Assistance Publique - H?pitaux de Paris |
Sarcoidosis|Cutaneous Sarcoidosis
|
2022-07 |
PHASE2 |
| NCT02753309 |
The University of Texas Health Science Center at San Antonio |
Bladder Cancer
|
2016-06 |
EARLY_PHASE1 |
| NCT02583893 |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
|
2015-10-07 |
PHASE2 |
| NCT01331135 |
Emory University|Children´s Healthcare of Atlanta |
Ewing´s Sarcoma|Osteosarcoma|Astrocytoma|Atypical Teratoid+Rhabdoid Tumor|Ependymoma|Germ Cell Tumor|Glioma|Medulloblastoma|Rhabdoid Tumor|Retinoblastoma|Clear Cell Sarcoma|Renal Cell Carcinoma|Wilms Tumor|Hepatoblastoma|Neuroblastoma|Rhabdomyosarcoma
|
2011-04 |
PHASE1 |
| NCT00305396 |
Vanderbilt University|Genzyme, a Sanofi Company |
Kidney Transplantation
|
2004-04 |
PHASE4 |
| NCT00266123 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Graft Rejection|Kidney Failure|Kidney Transplant
|
2004-03 |
PHASE4 |
| NCT00140543 |
EUROSPK Study Group|Fujisawa GmbH|Hoffmann-La Roche|Wyeth is now a wholly owned subsidiary of Pfizer|Neovii Biotech|Genzyme, a Sanofi Company |
Diabetes Mellitus, Type 1|Diabetic Nephropathy
|
2002-02 |
PHASE3 |
| NCT04236609 |
Concept Medical Inc. |
Diabetes|Coronary Artery Disease|Acute Coronary Syndrome
|
2020-06-15 |
NA |
| NCT03150914 |
University of Cincinnati|National Heart, Lung, and Blood Institute (NHLBI)|National Center for Advancing Translational Sciences (NCATS)|The LAM Foundation |
LAM|Lymphangioleiomyomatosis
|
2018-01-01 |
PHASE3 |
| NCT00589563 |
City of Hope Medical Center|National Cancer Institute (NCI) |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms|Precancerous Condition|Secondary Myelofibrosis|Small Intestine Cancer
|
2007-05 |
PHASE2 |
| NCT01049633 |
National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Type 1 Diabetes Mellitus
|
|
|
| NCT02588339 |
H. Lee Moffitt Cancer Center and Research Institute|Novartis |
Graft Versus Host Disease|GVHD
|
2016-03-04 |
PHASE2 |
| NCT03047980 |
Anne Comi, MD|Children´s Hospital Medical Center, Cincinnati|Pfizer|National Institutes of Health (NIH)|Faneca 66 Foundation|National Institute of Neurological Disorders and Stroke (NINDS) |
Sturge-Weber Syndrome
|
2017-01 |
PHASE2|PHASE3 |
| NCT00144703 |
Dana-Farber Cancer Institute|Brigham and Women´s Hospital |
Hematologic Malignancies|Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin´s Lymphoma|Hodgkin´s Disease
|
2002-07 |
PHASE2 |
| NCT01536054 |
Roswell Park Cancer Institute|National Cancer Institute (NCI)|Sanofi Pasteur, a Sanofi Company |
Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Epithelial Cancer|Stage IIA Primary Peritoneal Cavity Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Epithelial Cancer|Stage IIB Primary Peritoneal Cavity Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Epithelial Cancer|Stage IIC Primary Peritoneal Cavity Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Epithelial Cancer|Stage IIIA Primary Peritoneal Cavity Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Epithelial Cancer|Stage IIIB Primary Peritoneal Cavity Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Epithelial Cancer|Stage IIIC Primary Peritoneal Cavity Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Primary Peritoneal Cavity Cancer
|
2012-08-20 |
PHASE1 |
| NCT00233792 |
Cordis US Corp. |
Coronary Artery Disease
|
1999-12 |
PHASE1|PHASE2 |
| NCT06799195 |
University of Nebraska |
Hematological Malignancies|Graft-versus-Host Disease (GVHD)
|
2025-06-23 |
PHASE2 |
| NCT00509431 |
Jonsson Comprehensive Cancer Center |
Brain and Central Nervous System Tumors
|
2006-08 |
PHASE1 |
| NCT05663944 |
Nottingham University Hospitals NHS Trust |
Advanced Chronic Liver Disease
|
2022-07-25 |
PHASE2 |
| NCT04469530 |
Emory University|PeachBowl LegACy Fund |
Solid Tumor
|
2020-09-16 |
PHASE2 |
| NCT00634244 |
National Cancer Institute (NCI) |
Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia
|
2008-10 |
PHASE2 |
| NCT01684982 |
San Giuseppe Moscati Hospital |
Acute Myocardial Infarction
|
2007-04 |
PHASE4 |
| NCT00223054 |
University Hospital Schleswig-Holstein|University of Kiel |
Function of Renal Transplant
|
2005-03 |
|
| NCT03500848 |
Southern Medical University, China|First Affiliated Hospital, Sun Yat-Sen University|Nanfang Hospital, Southern Medical University |
Liver Transplantation
|
2018-05-01 |
PHASE2|PHASE3 |
| NCT02042326 |
Centre Hospitalier Universitaire, Amiens |
Arteriovenous Malformations
|
2014-09-12 |
PHASE2 |
| NCT02917096 |
City of Hope Medical Center|National Cancer Institute (NCI) |
Primary Myelofibrosis|Secondary Myelofibrosis
|
2016-11-13 |
PHASE1 |
| NCT00670423 |
Jennifer E. Schwartz|Millennium Pharmaceuticals, Inc. |
Graft vs Host Disease|Peripheral Blood Stem Cell Transplantation|Transplantation, Homologous
|
2008-05-16 |
PHASE1 |
| NCT03662412 |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
Pancreatic Cancer
|
2018-06-01 |
PHASE1|PHASE2 |
| NCT00693030 |
A.O. Ospedale Papa Giovanni XXIII|Case Western Reserve University|Medtronic Vascular|Boston Scientific Corporation |
Coronary Artery Disease
|
2006-08 |
PHASE4 |
| NCT05860881 |
Melanoma and Skin Cancer Trials Limited|Monash University|The University of Queensland |
Solid Organ Transplant Recipients|Skin Cancer
|
2024-02-09 |
PHASE3 |
| NCT07052929 |
Astellas Gene Therapies |
X-Linked Myotubular Myopathy
|
2025-12-15 |
PHASE1|PHASE2 |
| NCT02821507 |
Leiden University Medical Center |
Conventional Chondrosarcoma|Myxoid Liposarcoma|Mesenchymal Chondrosarcoma|Dedifferentiated Chondrosarcoma
|
2014-06 |
PHASE2 |
| NCT04370795 |
National Institute of Allergy and Infectious Diseases (NIAID) |
Severe Combined Immune Deficiency (SCID)
|
2025-11-26 |
PHASE1|PHASE2 |
| NCT01121744 |
Sahajanand Medical Technologies Limited |
Coronary Artery Disease
|
2010-04 |
NA |
| NCT04348292 |
Emory University|National Cancer Institute (NCI) |
Lung Non-Small Cell Carcinoma|Stage I Lung Cancer AJCC v8|Stage IA1 Lung Cancer AJCC v8|Stage IA2 Lung Cancer AJCC v8|Stage IA3 Lung Cancer AJCC v8|Stage IB Lung Cancer AJCC v8|Stage II Lung Cancer AJCC v8|Stage IIA Lung Cancer AJCC v8|Stage IIB Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8
|
2021-01-22 |
PHASE1 |
| NCT01134952 |
London Health Sciences Centre |
Hepatitis C
|
2010-06 |
PHASE4 |
| NCT07256249 |
Fundación EPIC |
Cardiovascular Diseases
|
2025-12-11 |
|
| NCT06261060 |
M.D. Anderson Cancer Center |
Familial Platelet Disorder|Hematopoietic
|
2024-06-20 |
PHASE2 |
| NCT01499888 |
University of Illinois at Chicago |
Sickle Cell Disease
|
2011-11-11 |
PHASE1|PHASE2 |
| NCT02891603 |
H. Lee Moffitt Cancer Center and Research Institute|CTI BioPharma|National Heart, Lung, and Blood Institute (NHLBI) |
Graft Vs Host Disease|GVHD
|
2017-06-08 |
PHASE1|PHASE2 |
| NCT04172922 |
Nemours Children´s Clinic |
Vascular Anomaly
|
2020-04-01 |
PHASE1 |
| NCT02513303 |
Vascular Therapies, Inc. |
Complication of Renal Dialysis|End Stage Renal Disease|End Stage Kidney Disease|ESRD|Chronic Kidney Failure|Complication of Hemodialysis|Vascular Access Complication|Arteriovenous Fistula
|
2015-11 |
PHASE3 |
| NCT01027000 |
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Genentech, Inc.|Biologics, Inc. |
Leukemia|Lymphoma
|
2010-02 |
PHASE2 |
| NCT04409691 |
Shanghai Children´s Medical Center |
Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
|
2020-07-01 |
PHASE1 |
| NCT05436418 |
National Cancer Institute (NCI) |
Peripheral Blood Stem Cell Transplantation|Hematopoietic Stem Cell Transplantation
|
2022-11-18 |
PHASE1|PHASE2 |
| NCT03972592 |
University Hospital, Tours|University Hospital, Angers |
Vascular Malformations|Lymphatic Malformation
|
2019-06-05 |
PHASE2 |
| NCT04411654 |
Prevail Therapeutics|Eli Lilly and Company |
Gaucher Disease, Type 2
|
2021-06-29 |
PHASE1|PHASE2 |
| NCT00392951 |
Children´s Hospital of Philadelphia |
Autoimmune Pancytopenia|Autoimmune Lymphoproliferative Syndrome (ALPS)|Evans Syndrome|Idiopathic Thrombocytopenic Purpura|Anemia, Hemolytic, Autoimmune|Autoimmune Neutropenia|Lupus Erythematosus, Systemic|Inflammatory Bowel Disease|Rheumatoid Arthritis
|
2006-12 |
PHASE1|PHASE2 |
| NCT01309022 |
National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) |
Diabetes Mellitus, Type 1
|
|
|
| NCT04896177 |
Shenzhen Salubris Pharmaceuticals Co., Ltd. |
Coronary Bifurcation Lesions
|
2021-03-18 |
NA |
| NCT06727305 |
University of Texas Southwestern Medical Center|University of Maryland, Baltimore|National Institute on Aging (NIA) |
Aging
|
2026-02 |
PHASE1|PHASE2 |
| NCT03077542 |
National Heart, Lung, and Blood Institute (NHLBI) |
Sickle Cell Disease
|
2017-04-06 |
PHASE1|PHASE2 |
| NCT03468478 |
Hospital do Rim e Hipertens?o |
Kidney Transplant Infection
|
2017-06-18 |
PHASE4 |
| NCT00957320 |
Emory University |
Acute Lymphoblastic Leukemia
|
2009-06 |
PHASE1 |
| NCT01116232 |
Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) |
Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms
|
2010-08 |
PHASE2 |
| NCT00434811 |
National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Type 1 Diabetes Mellitus
|
2006-10 |
PHASE3 |
| NCT02440789 |
Advancing Clinical Therapeutics Globally for HIV+AIDS and Other Infections|National Institute of Allergy and Infectious Diseases (NIAID) |
HIV-1 Infection
|
2015-12-21 |
PHASE1|PHASE2 |
| NCT00811616 |
Sahajanand Medical Technologies Limited |
Coronary Artery Disease
|
2006-07 |
NA |
| NCT00414648 |
University of Cincinnati|Office of Rare Diseases (ORD)|FDA Office of Orphan Products Development|National Center for Research Resources (NCRR) |
Lymphangioleiomyomatosis
|
2006-12 |
PHASE3 |
| NCT00368914 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
2004-12 |
PHASE1 |
| NCT00038948 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Renal Transplantation
|
2002-01 |
PHASE3 |
| NCT00656643 |
Santen Inc.|MacuSight, Inc. |
Diabetic Macular Edema
|
2008-06 |
PHASE2 |
| NCT02504307 |
Scitech Produtos Medicos SA |
Coronary Artery Disease
|
2015-07 |
PHASE4 |
| NCT00556933 |
University of Nebraska|Genzyme, a Sanofi Company |
End-stage Renal Disease
|
2004-04-01 |
PHASE4 |
| NCT07159087 |
Genoss Co., Ltd.|Synex Consulting Ltd |
Coronary Arterial Disease (CAD)
|
2025-02-19 |
NA |
| NCT02732899 |
Maturi, Raj K., M.D., P.C. |
Exudative Age Related Macular Degeneration
|
2016-04 |
PHASE2 |
| NCT01379209 |
Regimmune Corporation |
Graft Versus Host Disease
|
2011-09 |
PHASE1|PHASE2 |
| NCT01184885 |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University|American Society of Clinical Oncology |
Lymphoid Malignancies (New or Relapsed)|Acute Lymphoblastic Leukemia|Burkitt Lymphoma|Lymphoblastic Lymphoma|Mantle Cell Lymphoma|Adult T-cell Leukemia+Lymphoma
|
2010-07 |
EARLY_PHASE1 |
| NCT01592253 |
Seoul St. Mary´s Hospital |
Acute Rejection of Renal Transplant
|
2012-05 |
NA |
| NCT00146614 |
Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital |
Graft Versus Host Disease|Hematologic Malignancies
|
2002-07 |
PHASE2 |
| NCT00518375 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Kidney Transplantation
|
2000-04 |
PHASE4 |
| NCT01737502 |
Mayo Clinic|National Cancer Institute (NCI) |
Extensive Stage Small Cell Lung Carcinoma|Lung Adenocarcinoma|Recurrent Non-Small Cell Lung Carcinoma|Recurrent Small Cell Lung Carcinoma|Squamous Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer
|
2014-05-14 |
PHASE1|PHASE2 |
| NCT04161144 |
Medical University of South Carolina |
Smoking Cessation|Smoking, Cigarette|Nicotine Dependence
|
2018-10-01 |
PHASE2 |
| NCT03582878 |
Institute for Clinical and Experimental Medicine |
Diabetes Mellitus, Type 1
|
2004-01-01 |
PHASE4 |
| NCT02833506 |
Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Cancer|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer
|
2017-12-08 |
PHASE1 |
| NCT00141804 |
University Hospital Muenster|Proverum GmbH|KKS Netzwerk|Fujisawa GmbH |
Kidney Transplantation
|
2002-01 |
PHASE3 |
| NCT04177004 |
City of Hope Medical Center|National Cancer Institute (NCI) |
Allogeneic Hematopoietic Stem Cell Transplant Recipient|Hematopoietic and Lymphoid Cell Neoplasm
|
2021-04-30 |
PHASE1 |
| NCT07542314 |
Sarepta Therapeutics, Inc. |
Duchenne Muscular Dystrophy
|
2026-04-30 |
PHASE4 |
| NCT04341675 |
University of Cincinnati |
COVID-19
|
2020-04-24 |
PHASE2 |
| NCT01265030 |
MaineHealth|Desmoid Tumor Research Foundation|Pfizer |
Desmoid Tumor
|
2014-02 |
PHASE1|PHASE2 |
| NCT00195273 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Graft vs Host Disease|Kidney Transplantation
|
2004-11 |
PHASE3 |
| NCT00484094 |
Pfizer |
Kidney Transplantation
|
2011-07 |
|
| NCT02112981 |
Meril Life Sciences Pvt. Ltd. |
Coronary Artery Disease
|
2014-11-05 |
NA |
| NCT00014911 |
National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) |
Diabetes Mellitus, Insulin-Dependent
|
2001-04 |
PHASE2 |
| NCT03456700 |
Mayo Clinic |
Ovarian Serous Tumor|Recurrent Ovarian Carcinoma
|
2018-03-30 |
PHASE2 |
| NCT02152007 |
TransDerm, Inc.|Pachyonychia Congenita Project |
Pachyonychia Congenita
|
2014-01 |
PHASE1 |
| NCT00095329 |
National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence |
Multiple Sclerosis (MS) - Relapsing-remitting
|
2003-05 |
PHASE1|PHASE2 |
| NCT00353301 |
University of Colorado, Denver|Genentech, Inc. |
Renal Cell Carcinoma
|
2006-07 |
PHASE2 |
| NCT03765944 |
Nobelpharma |
Bioequivalence Study
|
2018-12-05 |
PHASE1 |
| NCT07378657 |
Ain Shams University |
Orbital Lymphatic Malformation
|
2025-11-01 |
PHASE3 |
| NCT01709136 |
University of Pittsburgh |
Hypertension
|
2005-12 |
PHASE2|PHASE3 |
| NCT04772300 |
Jena University Hospital|Concept Medical Inc.|Vascuscience|CoreLab Black Forest|Center for Clinical Studies Jena |
Peripheral Artery Disease
|
2022-02-10 |
NA |
| NCT03040934 |
Shanghai MicroPort Medical (Group) Co., Ltd. |
Drug-Eluting Stents|Percutaneous Coronary Intervention|Tomography, Optical Coherence
|
2017-11-10 |
NA |
| NCT00043979 |
National Cancer Institute (NCI) |
Sarcoma
|
2002-09-19 |
PHASE2 |
| NCT04511234 |
Concept Medical Inc. |
Peripheral Artery Disease|Atherosclerosis|Arterial Disease
|
2020-09-08 |
NA |
| NCT01809860 |
Astellas Pharma Global Development, Inc.|Basilea Pharmaceutica International Ltd |
Healthy Subjects|Pharmacokinetics of Isavuconazole|Pharmacokinetics of Sirolimus
|
2011-11 |
PHASE1 |
| NCT06802055 |
Peking Union Medical College Hospital |
Aplastic Anaemia
|
2025-01-25 |
PHASE2 |
| NCT00275535 |
Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer|Genzyme, a Sanofi Company|Roche Pharma AG |
Kidney Diseases
|
2001-04 |
PHASE4 |
| NCT00489281 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Sickle Cell Disease
|
2008-06-23 |
PHASE2 |
| NCT00406393 |
Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI) |
Leukemia, Myelocytic, Acute|Leukemia, Lymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes
|
2006-11 |
PHASE3 |
| NCT00240214 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Renal Transplantation
|
2001-04 |
|
| NCT02686619 |
Hoffmann-La Roche |
Renal Transplantation
|
2004-11 |
PHASE3 |
| NCT04534257 |
Singapore General Hospital |
Critical Lower Limb Ischemia|Peripheral Artery Disease
|
2020-09-09 |
NA |
| NCT05384756 |
City of Hope Medical Center|National Cancer Institute (NCI) |
Sickle Cell Disease
|
2022-07-13 |
PHASE1 |
| NCT01537107 |
Mayo Clinic |
Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific
|
2012-03-05 |
PHASE1 |
| NCT00188955 |
University of Manitoba|Wyeth is now a wholly owned subsidiary of Pfizer |
Kidney Transplantation
|
2004-03 |
PHASE4 |
| NCT00490789 |
Cardiff University|University of Nottingham|St Georges Hospital Medical School|Royal Sussex County Hospital|The Tuberous Sclerosis Association|Wyeth is now a wholly owned subsidiary of Pfizer |
Tuberous Sclerosis|Lymphangioleiomyomatosis
|
2005-10 |
PHASE2 |
| NCT04660240 |
Instituto Nacional de Cardiologia Ignacio Chavez |
Diabetes Mellitus|Coronary Artery Disease|Acute Coronary Syndrome
|
2020-10-01 |
NA |
| NCT05746689 |
Peking University International Hospital |
IgG4-related Disease
|
2023-03-01 |
NA |
| NCT06300268 |
Advanced MedTech Solutions Pvt. Ltd. |
Coronary Artery Disease|De Novo Stenosis Lesion|Coronary Stent Implantation
|
2024-06 |
NA |
| NCT00352976 |
Masonic Cancer Center, University of Minnesota |
Fanconi Anemia
|
2006-05-18 |
PHASE2|PHASE3 |
| NCT07151157 |
Ruijin Hospital |
Adult-Onset Still´s Disease
|
2025-08-30 |
NA |
| NCT01203722 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Hematologic Malignancies
|
2010-09 |
PHASE1|PHASE2 |
| NCT00023231 |
National Institute of Allergy and Infectious Diseases (NIAID) |
End-Stage Renal Disease
|
2001-02 |
NA |
| NCT04561739 |
Xijing Hospital |
De Novo Stenosis|Coronary Artery Disease
|
2021-02-01 |
NA |
| NCT02110069 |
Boston Children´s Hospital|Pfizer |
Kaposiform Hemangioendothelioma (KHE)|Kasabach-Merritt Syndrome|Tufted Angioma
|
2017-06-14 |
PHASE2 |
| NCT02123966 |
Dana-Farber Cancer Institute |
Chronic Graft-versus-Host-Disease|Oral Mucosal Disease Due to Graft-versus-host Disease
|
2014-07 |
PHASE2 |
| NCT05896839 |
National Cancer Institute (NCI) |
Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8|Metastatic Basal Cell Carcinoma|Metastatic Carcinoma in the Skin|Metastatic Melanoma|Metastatic Merkel Cell Carcinoma|Metastatic Skin Squamous Cell Carcinoma|Unresectable Basal Cell Carcinoma|Unresectable Melanoma|Unresectable Merkel Cell Carcinoma|Unresectable Skin Squamous Cell Carcinoma
|
2024-07-24 |
PHASE1|PHASE2 |
| NCT04083183 |
Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI) |
Non-Malignant Neoplasm
|
2020-06-16 |
PHASE1|PHASE2 |
| NCT00693446 |
Nantes University Hospital |
Pancreas Transplantation|Kidney Transplantation
|
2004-04 |
PHASE4 |
| NCT01428973 |
University of Liege|AZ Sint-Jan AV|Ziekenhuis Netwerk Antwerpen (ZNA)|Jules Bordet Institute|University Hospital, Gasthuisberg|Universitair Ziekenhuis Brussel|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|University Hospital, Antwerp|Cliniques Universitaires de Mont-Godinne|Hospital de Jolimont|University Hospital, Ghent|AZ Delta |
Graft-Versus-Host Disease|Hematological Malignancies
|
2011-09 |
PHASE2 |
| NCT00789308 |
National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Clinical Islet Transplantation Consortium |
Diabetes Mellitus, Type I
|
2008-07-11 |
PHASE2 |
| NCT04371640 |
Walter K. Kraft |
SARS-CoV-2|Covid-19
|
2020-07-06 |
PHASE1 |
| NCT05908331 |
Concept Medical Inc.|Cardiovascular Research Foundation, New York |
In-Stent Restenosis|Cardiovascular Diseases|Coronary Artery Disease
|
2024-04-16 |
NA |
| NCT06960928 |
Icahn School of Medicine at Mount Sinai|PolyBio Research Foundation|The Anlyan Center |
Long COVID-19
|
2025-04-18 |
PHASE3 |
| NCT00446264 |
University Hospital, Lille|Institut National de la Santé Et de la Recherche Médicale, France |
Type 1 Diabetes|Hypoglycemia|Metabolic Diseases
|
2003-05 |
PHASE2 |
| NCT02133287 |
Beijing AmsinoMed Medical Device Co., Ltd |
Ischemic Heart Disease|Myocardial Ischemia|Coronary Disease|Acute Coronary Syndrome
|
2013-08 |
NA |
| NCT05324384 |
West China Hospital |
Hemangioendothelioma
|
2022-04-05 |
PHASE2 |
| NCT00346918 |
University of Zurich |
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
2006-06 |
PHASE3 |
| NCT00061568 |
National Heart, Lung, and Blood Institute (NHLBI) |
Congenital Hemolytic Anemia|Sickle Cell Disease
|
2004-07-16 |
PHASE1|PHASE2 |
| NCT03688191 |
Peking Union Medical College Hospital |
Connective Tissue Diseases|Thrombocytopenia
|
2017-09-21 |
PHASE4 |
| NCT01446484 |
Pirogov Russian National Research Medical University|Russian Academy of Medical Sciences |
End-Stage Renal Disease|Kidney Failure
|
2011-10 |
PHASE1|PHASE2 |
| NCT00518271 |
Wyeth is now a wholly owned subsidiary of Pfizer |
Kidney Transplantation
|
2000-04 |
PHASE2 |
| NCT01632605 |
Medical University of Vienna |
ADPKD
|
2009-11 |
NA |
| NCT00766649 |
National Eye Institute (NEI) |
Age-Related Macular Degeneration
|
2008-10 |
PHASE1|PHASE2 |
| NCT00005113 |
Boston Children´s Hospital |
End-Stage Renal Disease|Kidney Transplantation
|
1999-07 |
PHASE3 |
| NCT01453140 |
Hackensack Meridian Health |
Graft Versus Host Disease
|
2011-08 |
PHASE1|PHASE2 |